Oncolix, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows, 12 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-10-05: Reporting owner Health Sciences Center LLC; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2017-10-05: Reporting owner Health Sciences Center LLC; Form 3; Security Warrant to acquire Series A Preferred; Transaction Holding.
- 2017-08-11: Reporting owner TEXAS TREASURY SAFEKEEPING TRUST CO; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2017-08-11: Reporting owner TEXAS TREASURY SAFEKEEPING TRUST CO; Form 3; Security Series A Preferred Stock Purchase Warrant; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-10-05 holding as of filing | Health Sciences Center LLC 10% Owner | 3 | Series A Preferred Stock Non-derivative · Direct | Holding | 19,938,500 owned after | no price filed | 2017-10-05 | |
| 2017-10-05 holding as of filing | Health Sciences Center LLC 10% Owner | 3 | Warrant to acquire Series A Preferred Derivative · Direct | Holding | $0.08 exercise price | 2017-10-05 | ||
| 2017-08-11 holding as of filing | TEXAS TREASURY SAFEKEEPING TRUST CO 10% Owner | 3 | Series A Preferred Stock Non-derivative · Direct | Holding | 36,172,180 owned after | no price filed | 2017-08-11 | |
| 2017-08-11 holding as of filing | TEXAS TREASURY SAFEKEEPING TRUST CO 10% Owner | 3 | Series A Preferred Stock Purchase Warrant Derivative · Direct | Holding | $0.08 exercise price | 2017-08-11 | ||
| 2017-08-11 holding as of filing | Greenville Health Research Development Corp 10% Owner | 3 | Series A Preferred Stock Non-derivative · Direct | Holding | 19,938,500 owned after | no price filed | 2017-08-11 | |
| 2017-08-11 holding as of filing | Greenville Health Research Development Corp 10% Owner | 3 | Warrant to acquire Series A Preferred Derivative · Direct | Holding | $0.08 exercise price | 2017-08-11 | ||
| 2017-08-03 | Redman Michael Thomas Director, Officer (President) | 4 | Series A Preferred Stock Non-derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | no price filed | 2017-09-14 | |
| 2017-08-03 | Redman Michael Thomas Director, Officer (President) | 4 | Series A Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $0.08 exercise price | 2017-09-14 | |
| 2017-08-03 | Redman Michael Thomas Director, Officer (President) | 4 | Warrant to acquire Series A Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $0.08 exercise price | 2017-09-14 | |
| 2017-08-03 | PAYNE J DONALD Director, Officer (Secretary) | 4 | Series A Preferred Stock Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | no price filed | 2017-08-07 | |
| 2017-08-03 | PAYNE J DONALD Director, Officer (Secretary) | 4 | Series A Preferred Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $0.08 exercise price | 2017-08-07 | |
| 2017-08-03 | PAYNE J DONALD Director, Officer (Secretary) | 4 | Warrant to acquire Series A Preferred Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 28,000 owned after | $0.08 exercise price | 2017-08-07 |